Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention
-
Narrado por:
-
De:
In this episode, our editor-in-chief Taissa Vila sits down with Dr. Beatriz Grinsztejn to discuss the challenges of expanding access to pre-exposure prophylaxis (PrEP), with a focus on issues of adherence and equity in Latin America.
We explore the potential of Lenacapavir as a game-changing intervention, reflect on lessons learned from previous experiences with injectable PrEP, and examine the critical importance of introducing new prevention tools through an equity-based approach.
Finally, we look ahead to what Lenacapavir could mean for the future of HIV prevention strategies worldwide. Tune in for an insightful conversation on how innovative strategies like Lenacapavir could reshape the future of HIV awareness and prevention.
Read the full article:
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00156-5/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laname